• Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Joining the Fight Against Diabetes
24 Jul 2023

According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.

Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.

The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.

Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.

This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.

Topics:

Brands:

Related Stories

Premier Integrated Labs Transforms Operations with Cutting-edge Haematology System

On 16 October, Premier Integrated Labs redefined laboratory excellence with Malaysia’s first AI-assisted, fully automated haematology system in private practice, shaping the future of diagnostic innovation. 

24 Jul 2023
Read More

Transforming Our Future: A Decade of Quality & Safety

The 10th IHH Healthcare Quality Summit 2025 in Hong Kong brought together more than 200 leaders, clinicians and quality champions from across our global network to reaffirm our commitment to clinical excellence, patient safety, and transformative care.

24 Jul 2023
Read More

Pantai Hospital Kuala Lumpur Powers Malaysia’s Biggest Marathon with Heart

Every effort counts with a record-breaking 42,000 participants registering for the 17th edition of Malaysia’s premier distance running event. 

24 Jul 2023
Read More

Gleneagles MediCentre Opens in Hong Kong, Redefining Smart and Seamless Care

Step inside a new era of connected, technology-enabled care designed around patients’ needs.

24 Jul 2023
Read More

Celebrating the D.N.A. of Excellence across IHH Labs

The recent IHH Labs Townhall was especially meaningful as we celebrated the achievements of our medical technologists - the very backbone of IHH Laboratories - through the launch of the Global IHH Labs D.N.A. Award, which stands for Discovery, Nurturing, and Accuracy.

24 Jul 2023
Read More

IHH Healthcare Shines at The Economic Times Healthcare Awards 2025

Explore the award-winning care and innovation across our network.

24 Jul 2023
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo